 |
인쇄하기
취소
|
EDQM approves EstechPharma’s acamprosate calcium
EstechPharma says the European Directorate for Quality Medicines (EDQM) has certified its acamprosate calcium, anti-alcoholic medicine.
With the EDQM’s approval of acamprosate calcium, the company is poised to make quicker inroads to the European market.
The EDQM is responsible for facilitating mutual recognition between European countries of quality control tests carried out on medicines...
With the EDQM’s approval of acamprosate calcium, the company is poised to make quicker inroads to the European market.
The EDQM is responsible for facilitating mutual recognition between European countries of quality control tests carried out on medicines...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.